Riabni multiple strengths Images
Generic Name: rituximab
This medication has been identified as Riabni multiple strengths and is used for Granulomatosis with Polyangiitis, Follicular Lymphoma, Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, and Microscopic Polyangiitis. It belongs to the drug class CD20 monoclonal antibodies and is not a controlled substance.
Images of medication
Riabni
- Generic Name
- rituximab
- Strength
- multiple strengths
- Availability
- Prescription only
- Drug Class
- CD20 monoclonal antibodies
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Amgen Inc.
- National Drug Code (NDC)
- multiple
See also:
More about Riabni (rituximab)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: CD20 monoclonal antibodies
- Breastfeeding
- En español
Patient resources
- Riabni drug information
- Riabni (Rituximab Intravenous) (Advanced Reading)
- Riabni (Rituximab-arrx Intravenous) (Advanced Reading)
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.